In a recent study, it was shown that silencing of total ERβ in MDA-MB-231 TNBC cells expressing mutant TP53 resulted in decreased expression of TP53-target genes, leading to tumor growth and reduced apoptosis [44]. This evidence concerns the gene TP53 and neoplasm.